Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder

Clinical Therapeutics

Volumn 30, Issue 9, 2008, Pages 1565-1589

  Houthoofd, Sofie A M K ^a   Morrens, Manuel ^a   Sabbe, Bernard G C ^a,b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b Sint Norbertushospital   (Belgium)

Author keywords

cognition; MATRICS; psychomotor; risperidone; schizoaffective disorder; schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; HALOPERIDOL; LONG ACTING DRUG; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ALERTNESS; ARTICLE; ATTENTION; CLINICAL TRIAL; COGNITION; CRITICAL THINKING; DRUG EFFECT; FUNCTIONAL ASSESSMENT; HUMAN; INFORMATION PROCESSING; LEARNING; MEASUREMENT AND TREATMENT RESEARCH TO IMPROVE COGNITION IN SCHIZOPHRENIA; MEDLINE; NEUROLOGIC EXAMINATION; PERFORMANCE; PROBLEM SOLVING; PSYCHOLOGIC ASSESSMENT; PSYCHOMOTOR ACTIVITY; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SOCIAL INTERACTION; SPEECH; TREATMENT OUTCOME; VERBAL FLUENCY; VERBAL MEMORY; VISUAL MEMORY; WORKING MEMORY;

ANTIPSYCHOTIC AGENTS; ATTENTION; COGNITION; COGNITION DISORDERS; DOUBLE-BLIND METHOD; HUMANS; PSYCHOTIC DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISPERIDONE; SCHIZOPHRENIA; VERBAL LEARNING;

EID: 53049101046     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2008.09.014     Document Type: Article

References (83)

1. Lewis R. Should cognitive deficit be a diagnostic criterion for schizophrenia?. J Psychiatry Neurosci 29 (2004) 102-113
2. Snitz B.E., Macdonald III A.W., and Carter C.S. Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: A meta-analytic review of putative endophenotypes. Schizophr Bull 32 (2006) 179-194
3. Appels M.C., Sitskoorn M.M., Westers P., et al. Cognitive dysfunctions in parents of schizophrenic patients parallel the deficits found in patients. Schizophr Res 63 (2003) 285-293
4. Green M.F., Nuechterlein K.H., Gold J.M., et al. Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry 56 (2004) 301-307
5. Nuechterlein K.H., Barch D.M., and Gold J.M. Identification of separable cognitive factors in schizophrenia. Schizophr Res 72 (2004) 29-39
6. Morrens M., Hulstijn W., and Sabbe B. Psychomotor slowing in schizophrenia. Schizophr Bull 33 (2007) 1038-1053
7. Woodward N.D., Purdon S.E., Meltzer H.Y., and Zald D.H. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Int J Neuropsychopharmacol 8 (2005) 457-472
8. Woodward N.D., Purdon S.E., Meltzer H.Y., and Zald D.H. A meta-analysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: Dose effects and comparison to practice effects. Schizophr Res 89 (2007) 211-224
9. Purdon S.E. Cognitive improvement in schizophrenia with novel antipsychotic medications. Schizophr Res 35 (1999) S51-S60
10. Keefe R.S., Silva S.E., Perkins D.O., and Lieberman J.A. The effects of atypical antipsychotics on neurocognitive impairment in schizophrenia: A review and meta-analysis. Schizophr Bull 25 (1999) 201-222
11. MATRICS Assessment, Inc. MATRICS Consensus Cognitive Battery [MAI Web site] (September 16, 2008). http://www.matricsinc.org/mccb.htm Accessed
12. Royer F.L., Gilmore G.C., and Gruhn J.J. Normative data for the Symbol Digit Substitution Task. J Clin Psychol 37 (1981) 608-614
13. Wechsler D. Wechsler Memory Scale-Revised (1987), Psychological Corporation, San Antonio, Tx
14. Ardila A. Normal aging increases cognitive heterogeneity: Analysis of dispersion in WAIS-III scores across age. Arch Clin Neuropsychol 22 (2007) 1003-1011
15. Ryan J.J., Sattler J.M., and Lopez S.J. Age effects on Wechsler Adult Intelligence Scale-III subtests. Arch Clin Neuropsychol 15 (2000) 311-317
16. Keefe R.S., Mohs R.C., Bilder R.M., et al. Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: Development, methodology, and rationale. Schizophr Bull 29 (2003) 45-55
17. Tombaugh T.N. Trail Making Test A and B: Normative data stratified by age and education. Arch Clin Neuropsychol 19 (2004) 203-214
18. Van der Elst W., Van Boxtel M.P., Van Breukelen G.J., and Jolles J. The Stroop color-word test: Influence of age, sex, and education; and normative data for a large sample across the adult age range. Assessment 13 (2006) 62-79
19. Keefe R.S., Goldberg T.E., Harvey P.D., et al. The Brief Assessment of Cognition in Schizophrenia: Reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res 68 (2004) 283-297
20. Keefe R.S., Harvey P.D., Goldberg T.E., et al. Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS). Schizophr Res 102 (2008) 108-115
21. Gladsjo J.A., Schuman C.C., Evans J.D., et al. Norms for letter and category fluency: Demographic corrections for age, education, and ethnicity. Assessment 6 (1999) 147-178
22. Ruff R.M., and Parker S.B. Gender- and age-specific changes in motor speed and eye-hand coordination in adults: Normative values for the Finger Tapping and Grooved Pegboard Tests. Percept Mot Skills 76 (1993) 1219-1230
23. Morrens M., Hulstijn W., and Sabbe B. The effects of atypical and conventional antipsychotics on reduced processing speed and psychomotor slowing in schizophrenia: A cross-sectional exploratory study. Clin Ther 30 (2008) 684-692
24. Chen W.J., Hsiao C.K., Hsiao L.L., and Hwu H.G. Performance of the Continuous Performance Test among community samples. Schizophr Bull 24 (1998) 163-174
25. Cornblatt B.A., Risch N.J., Faris G., et al. The Continuous Performance Test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families. Psychiatry Res 26 (1988) 223-238
26. Beck L.H., Bransome Jr. E.D., Mirsky A.F., et al. A continuous performance test of brain damage. J Consult Psychol 20 (1956) 343-350
27. Wechsler D. Wechsler Memory Scale. 3rd ed. (1997), Psychological Corporation, San Antonio, Tx
28. Ryan J.J., Arb J.D., and Ament P.A. Supplementary WMS-III tables for determining primary subtest strengths and weaknesses. Psychol Assess 12 (2000) 193-196
29. McGurk S.R., Green M.F., Wirshing W.C., et al. Antipsychotic and anticholinergic effects on two types of spatial memory in schizophrenia. Schizophr Res 68 (2004) 225-233
30. Lyons-Warren A., Lillie R., and Hershey T. Short- and long-term spatial delayed response performance across the lifespan. Dev Neuropsychol 26 (2004) 661-678
31. Keefe R.S., Roitman S.E., Harvey P.D., et al. A pen-and-paper human analogue of a monkey prefrontal cortex activation task: Spatial working memory in patients with schizophrenia. Schizophr Res 17 (1995) 25-33
32. Gutbrod K., Cohen R., Mager B., et al. Coding and recall of categorized material in aphasics. J Clin Exp Neuropsychol 11 (1989) 821-841
33. Norman M.A., Evans J.D., Miller W.S., and Heaton R.K. Demographically corrected norms for the California Verbal Learning Test. J Clin Exp Neuropsychol 22 (2000) 80-94
34. Harvey P.D., Howanitz E., Parrella M., et al. Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: A comparison across treatment sites. Am J Psychiatry 155 (1998) 1080-1086
35. Hogervorst E., Combrinck M., Lapuerta P., et al. The Hopkins Verbal Learning Test and screening for dementia. Dement Geriatr Cogn Disord 13 (2002) 13-20
36. Vanderploeg R.D., Schinka J.A., Jones T., et al. Elderly norms for the Hopkins Verbal Learning Test-Revised. Clin Neuropsychol 14 (2000) 318-324
37. Rey A. Clinical and Psychological Examination [in French] (1964), Presses Universitaires de France, Paris, France
38. Van der Elst W., Van Boxtel M.P., van Breukelen G.J., and Jolles J. Rey's verbal learning test: Normative data for 1855 healthy participants aged 24-81 years and the influence of age, sex, education, and mode of presentation. J Int Neuropsychol Soc 11 (2005) 290-302
39. Green P., and Kramer E. Auditory Comprehension Tests (1983), Auditory Comprehension Tests Ltd, Edmonton, Alberta, Canada
40. Benedict R.H. Brief Visuospatial Memory Test-Revised (1997), Psychological Assessment Resources, Inc, Odessa, Fla
41. Gale S.D., Baxter L., Connor D.J., et al. Sex differences on the Rey Auditory Verbal Learning Test and the Brief Visuospatial Memory Test-Revised in the elderly: Normative data in 172 participants. J Clin Exp Neuropsychol 29 (2007) 561-567
42. Osterrieth P.A. The Complex Figure Copy Test [in French]. Arch Psychol 30 (1944) 206-356
43. Fastenau P.S., Denburg N.L., and Hufford B.J. Adult norms for the Rey-Osterrieth Complex Figure Test and for supplemental recognition and matching trials from the Extended Complex Figure Test. Clin Neuropsychol 13 (1999) 30-47
44. Awad N., Tsiakas M., Gagnon M., et al. Explicit and objective scoring criteria for the Taylor Complex Figure Test. J Clin Exp Neuropsychol 26 (2004) 405-415
45. Boone K.B., Ghaffarian S., Lesser I.M., et al. Wisconsin Card Sorting Test performance in healthy, older adults: Relationship to age, sex, education, and IQ. J Clin Psychol 49 (1993) 54-60
46. Wechsler D. Wechsler Adult Intelligence Scale. 3rd ed. (1997), Psychological Corporation, San Antonio, Tx
47. Wechsler D. Wechsler Intelligence Scale for Children. 3rd ed. (1991), Psychological Corporation, San Antonio, Tx
48. Gallhofer B., Lis S., Meyer-Lindenberg A., and Krieger S. Cognitive dysfunction in schizophrenia: A new set of tools for the assessment of cognition and drug effects. Acta Psychiatr Scand Suppl 395 (1999) 118-128
49. Iverson G., Brooks B., White T., et al. Neuropsychological Assessment Battery (NAB): Introduction and advanced interpretation. In: Horton Jr. A.M., and Wedding D. (Eds). The Neuropsychology Handbook. 3rd ed. (2007), Springer, New York, NY 281-346
50. Skaar N.R. Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT). Assessment for Effective Intervention 33 (2007) 47-50
51. Bellack A.S., Morrison R.L., Wixted J.T., and Mueser K.T. An analysis of social competence in schizophrenia. Br J Psychiatry 156 (1990) 809-818
52. Patterson T.L., Moscona S., McKibbin C.L., et al. Social skills performance assessment among older patients with schizophrenia. Schizophr Res 48 (2001) 351-360
53. Erwin R.J., Gur R.C., Gur R.E., et al. Facial emotion discrimination: I. Task construction and behavioral findings in normal subjects. Psychiatry Res 42 (1992) 231-240
54. Purdon S.E., Jones B.D., Stip E., et al., Canadian Collaborative Group for Research in Schizophrenia. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. Arch Gen Psychiatry 57 (2000) 249-258
55. Harvey P.D., Green M.F., McGurk S.R., and Meltzer H.Y. Changes in cognitive functioning with risperidone and olanzapine treatment: A large-scale, double-blind, randomized study. Psychopharmacology (Berl) 169 (2003) 404-411
56. Harvey P.D., Napolitano J.A., Mao L., and Gharabawi G. Comparative effects of risperidone and olanzapine on cognition in elderly patients with schizophrenia or schizoaffective disorder. Int J Geriatr Psychiatry 18 (2003) 820-829
57. Bellack A.S., Schooler N.R., Marder S.R., et al. Do clozapine and risperidone affect social competence and problem solving?. Am J Psychiatry 161 (2004) 364-367
58. Rémillard S., Pourcher E., and Cohen H. The effect of neuroleptic treatments on executive function and symptomatology in schizophrenia: A 1-year follow-up study. Schizophr Res 80 (2005) 99-106
59. Harvey P.D., Rabinowitz J., Eerdekens M., and Davidson M. Treatment of cognitive impairment in early psychosis: A comparison of risperidone and haloperidol in a large long-term trial. Am J Psychiatry 162 (2005) 1888-1895
60. McGurk S.R., Carter C., Goldman R., et al. The effects of clozapine and risperidone on spatial working memory in schizophrenia. Am J Psychiatry 162 (2005) 1013-1016
61. Harvey P.D., Patterson T.L., Potter L.S., et al. Improvement in social competence with short-term atypical antipsychotic treatment: A randomized, double-blind comparison of quetiapine versus risperidone for social competence, social cognition, and neuropsychological functioning. Am J Psychiatry 163 (2006) 1918-1925
62. Lee S.M., Chou Y.H., Wan F.J., and Yen M.H. Effects of antipsychotics on cognitive performance in drug-naive schizophrenic patients. Prog Neuro-psychopharmacol Biol Psychiatry 31 (2007) 1101-1107
63. Keefe R.S., Sweeney J.A., Gu H., et al. Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: A randomized, double-blind 52-week comparison. Am J Psychiatry 164 (2007) 1061-1071
64. Riedel M., Spellmann I., Strassnig M., et al. Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms. Eur Arch Psychiatry Clin Neurosci 257 (2007) 360-370
65. Palmer B.W., and Heaton R.K. Executive dysfunction in schizophrenia. In: Sharma T., and Harvey P. (Eds). Cognition in Schizophrenia (2005), Oxford University Press Inc, New York, NY 58
66. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (1994), American Psychological Press, Arlington, Va
67. Kay S.R., Fiszbein A., and Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13 (1987) 261-276
68. Lehrl S. Mehrfachwahl-Wortschatz-Intelligenztest. Manual zum MWT-V (1977), Erlangen, Straube, Germany
69. Lezak M. Neuropsychological Assessment. 3rd ed. (1995), Oxford University Press, New York, NY
70. Green M.F., Kern R.S., Robertson M.J., et al. Relevance of neurocognitive deficits for functional outcome in schizophrenia. In: Sharma T., and Harvey P. (Eds). Cognition in Schizophrenia (2005), Oxford University Press Inc, New York, NY 179
71. Keefe R. Working memory dysfunction and its relevance to schizophrenia. In: Sharma T., and Harvey P. (Eds). Cognition in Schizophrenia (2005), Oxford University Press Inc, New York, NY 16-19
72. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised (1987), APA, Washington, DC
73. Kane J., Honigfeld G., Singer J., and Meltzer H. Clozapine for the treatment resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45 (1988) 789-796
74. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders. Third Edition (1980), APA, Washington, DC
75. Kraepelin E. In: Barclay R.M., and Robertson G.M. (Eds). Dementia praecox and paraphrenia [1919] (1971), Robert E. Krieger, New York, NY
76. Bleuler E. Dementia Praecox or Group of Schizophrenias [1911]. Trans. Zinkin J (1950), International Universities Press, New York, NY
77. Pandina G., Bouhours P., Lasser R.A., et al. Improved cognition observed in patients with schizophrenia with risperidone long-acting injectable. Presented at: 18th European College of Neuropsychopharmacology (ECNP) Congress (October 22-26, 2005) Amsterdam, The Netherlands
78. Harvey P.D., Pandina G., Bilder R.M., et al. Cognitive and functional improvement with long term treatment with long-acting risperidone. Presented at: 44th Annual Meeting of the American College of Neuropsychopharmacology (December 11-15, 2005) Waikoloa, Hawaii
79. Bilder R., Pandina G., Lasser R., et al. Cognitive and functional improvement with long-acting risperidone treatment. Presented at: 159th Annual Meeting of the American Psychiatric Association (May 20-25, 2006) Toronto, Ontario, Canada
80. Bouhours P., Lasser R., Pandina G., et al. Cognitive and functional improvement with long-acting risperidone treatment. Presented at: World Federation of Societies of Biological Psychiatry Annual Meeting (June 28-July 3, 2005) Vienna, Austria
81. Mattys J. Improved cognition observed in patients with schizophrenia with risperidone long-acting injectable. Presented at: 18th European College of Neuropsychopharmacology Congress (October 22-26, 2005) Amsterdam, The Netherlands
82. Ventura J., Cienfuegos A., Boxer O., and Bilder R. Clinical global impression of cognition in schizophrenia (CGI-CogS): Reliability and validity of a co-primary measure of cognition [Science Direct Web site]. Schizophr Res (September 25, 2007-August 26, 2008). http://www.sciencedirect.com Accessed
83. Harvey P.D., and Keefe R.S. Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. Am J Psychiatry 158 (2001) 176-184